Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Astec LifeSciences has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 25th January, 2022, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine Months’ period ended 31st December, 2021 (subject to limited review by the Statutory Auditors of the Company), after these results are reviewed by the Audit Committee.
The above information is a part of company’s filings submitted to BSE.
